P-LLY PP-ZP-US-0986 08/2024 Lilly USA, LLC 2024
In the SURMOUNT-1 trial, 95 percent of participants taking tirzepatide reverted to normal blood sugar over 176 weeks, and 99 percent stayed diabetes-free
In a recent study, 92% of patients achieved their goals on the Programme alone
Ninety percent of the AIA-positive patients on TOUJEO with antibody test at baseline, remained AIA positive at month 6
Successful Phase 2 and Phase 3 clinical trials have shown that bremelanotide has a modest yet statistically significant impact on patients sexual desire when self-administered up to 2 hours prior to intercourse [2]
Signs of dehydration (extreme thirst, dizziness, dark urine, reduced urination) also require prompt medical attention